Related Experiment Videos
Toward a genome-scale understanding of group A Streptococcus pathogenesis
1Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 903 South 4th Street, Hamilton, MT 59840, USA.
Current Opinion in Microbiology
|February 15, 2001
Summary
Group A Streptococcus (GAS) pathogenesis research has advanced with new discoveries in regulatory pathways and toxin structures. Genome-scale studies are emerging to deepen understanding of host-pathogen interactions.
Area of Science:
- Microbiology and Infectious Diseases
- Molecular Pathogenesis
- Genomics
Background:
- Group A Streptococcus (GAS) is a significant human pathogen responsible for various infections.
- Understanding GAS pathogenesis is crucial for developing effective treatments and prevention strategies.
Purpose of the Study:
- To summarize recent advances in understanding Group A Streptococcus pathogenesis.
- To highlight the emergence of genome-scale approaches in studying GAS-host interactions.
Main Methods:
- Review of recent significant contributions to GAS pathogenesis research.
- Identification of newly discovered regulatory pathways.
- Analysis of reported crystal structures of GAS toxins.
- Consideration of a recently determined GAS strain genome sequence.
Main Results:
- New regulatory pathways in GAS pathogenesis have been identified.
- Insights into the molecular basis of serotype M1 disease epidemics have been gained.
- Crystal structures for four GAS toxins have been determined.
- A complete genome sequence for a GAS strain is now available.
Conclusions:
- Significant progress has been made in understanding GAS pathogenesis.
- Genome-scale approaches are rapidly emerging and will enhance fundamental knowledge of GAS-host interactions.